Topic

Brent Herspiegel is the CEO of Herspiegel Consulting.

Beth Schurman is the COO of Herspiegel Consulting.

Articles

When deciding on the right commercialization model, organizations must consider multiple factors, including the asset or platform they possess, the launch timing, the funding required, and staffing expertise.

When to Utilize Commercial Outsourcing 

A discussion with medical leaders on the present and future state of this vital biopharmaceutical function.

Biopharma Medical Affairs: Where We’ve Been and Where We’re Headed 

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Industry insights on how pharma is faring in tapping new innovations and approaches in digital health. 

Pharma 2023: Digital Health Key Takeaways

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Pharma USA 2023: Digital Therapeutics and Pharma

Regardless of engagement mode pursued, personalization is the key.

How to Connect with HCPs More Effectively

Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data. 


Pharma USA 2023: Changes to the Medical Affairs Function

Looking at corporate value through a portfolio lens provides an astute and reliable path to genuine value creation. 






Value Creation Through Portfolio-Based Corporate Strategy

Global medical affairs teams seek better support to manage relationships with key opinion leaders—and find that balance between patient needs, scientific objectives, and the interest areas of KOLs.

Being KOL-Centric: More Meaningful Expert Engagement

Pharm Exec spoke with Skalicky about new ways that life sciences companies are engaging with outsourcing.

Q&A with Greg Skalicky, President and Chief Revenue Officer of Eversana

Michael Wong is an emeritus board member of the Harvard Business School Healthcare Alumni Association (HBSHAA).

Author Deepa Purushothaman discusses the progress of women and women of color in corporate America.